AU4497199A - Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections - Google Patents
Cd4 radio-immunological pharmaceuticals for the treatment of hiv infectionsInfo
- Publication number
- AU4497199A AU4497199A AU44971/99A AU4497199A AU4497199A AU 4497199 A AU4497199 A AU 4497199A AU 44971/99 A AU44971/99 A AU 44971/99A AU 4497199 A AU4497199 A AU 4497199A AU 4497199 A AU4497199 A AU 4497199A
- Authority
- AU
- Australia
- Prior art keywords
- radio
- treatment
- hiv infections
- immunological
- pharmaceuticals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19826307 | 1998-04-15 | ||
DE1998126307 DE19826307A1 (en) | 1998-03-08 | 1998-04-15 | CD4 radio immunological pharmaceuticals |
PCT/DE1999/001177 WO1999054954A2 (en) | 1998-04-15 | 1999-04-15 | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4497199A true AU4497199A (en) | 1999-11-08 |
Family
ID=7870747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44971/99A Abandoned AU4497199A (en) | 1998-04-15 | 1999-04-15 | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1071475A2 (en) |
JP (1) | JP2002512261A (en) |
AU (1) | AU4497199A (en) |
DE (1) | DE19980721D2 (en) |
WO (1) | WO1999054954A2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05502218A (en) * | 1989-09-14 | 1993-04-22 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | Therapeutic composition; method for treating HIV infection |
JPH04506460A (en) * | 1990-01-26 | 1992-11-12 | バイオジェン,インコーポレイテッド | C4 binding protein fusion protein |
GB9217124D0 (en) * | 1992-08-13 | 1992-09-23 | Antisoma Ltd | Medical treatment |
WO1997003198A2 (en) * | 1995-07-07 | 1997-01-30 | Texas A & M University System | Nucleotide and amino acid sequence and uses thereof |
DE19809785C2 (en) * | 1998-03-08 | 2000-02-10 | Wolfgang Bergter | Radioimmune drug for the treatment of HIV-1 infection |
-
1999
- 1999-04-15 JP JP2000545211A patent/JP2002512261A/en active Pending
- 1999-04-15 AU AU44971/99A patent/AU4497199A/en not_active Abandoned
- 1999-04-15 WO PCT/DE1999/001177 patent/WO1999054954A2/en not_active Application Discontinuation
- 1999-04-15 EP EP99927685A patent/EP1071475A2/en not_active Withdrawn
- 1999-04-15 DE DE19980721T patent/DE19980721D2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2002512261A (en) | 2002-04-23 |
EP1071475A2 (en) | 2001-01-31 |
WO1999054954A2 (en) | 1999-10-28 |
DE19980721D2 (en) | 2001-03-29 |
WO1999054954A3 (en) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0001539A3 (en) | 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same | |
AU6405198A (en) | Plant for the treatment of products, which includes means for characterizing the products | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
AU3813499A (en) | The use of dihydropyrimidines as medicaments, and novel substances | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
EP0604182A3 (en) | Inhibitors of HIV protease useful for the treatment of Aids. | |
AU3118200A (en) | Hiv integrase inhibitors | |
AU6616400A (en) | Hiv integrase inhibitors | |
AU6062498A (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use | |
AU1285300A (en) | Hiv vaccine | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU2759800A (en) | Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils | |
AU6119699A (en) | Highly branched oligomers, process for their preparation and applications thereof | |
AU1408300A (en) | Hiv infection inhibitors | |
AU8009900A (en) | Hiv integrase inhibitors | |
AU5252993A (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
AU4135493A (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
EP1143990A3 (en) | Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections | |
AU4145999A (en) | Topical drug for the treatment of viral infections | |
AU3714800A (en) | Hiv therapy | |
AU5494298A (en) | Pharmaceutical compositions for the treatment of the eye | |
AU4497199A (en) | Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |